全文获取类型
收费全文 | 136篇 |
免费 | 13篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 1篇 |
妇产科学 | 1篇 |
基础医学 | 14篇 |
口腔科学 | 2篇 |
临床医学 | 14篇 |
内科学 | 64篇 |
皮肤病学 | 5篇 |
神经病学 | 7篇 |
特种医学 | 4篇 |
外科学 | 17篇 |
综合类 | 2篇 |
预防医学 | 3篇 |
眼科学 | 5篇 |
药学 | 7篇 |
肿瘤学 | 4篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 12篇 |
2020年 | 7篇 |
2019年 | 4篇 |
2018年 | 9篇 |
2017年 | 3篇 |
2016年 | 5篇 |
2015年 | 7篇 |
2014年 | 9篇 |
2013年 | 5篇 |
2012年 | 8篇 |
2011年 | 3篇 |
2010年 | 4篇 |
2009年 | 4篇 |
2008年 | 5篇 |
2007年 | 13篇 |
2006年 | 7篇 |
2005年 | 7篇 |
2004年 | 10篇 |
2003年 | 9篇 |
2002年 | 10篇 |
2000年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1988年 | 1篇 |
1967年 | 1篇 |
排序方式: 共有151条查询结果,搜索用时 15 毫秒
21.
Luca Testa William Van Gaal Giuseppe Biondi-Zoccai Antonio Abbate Graziana Trotta Pierfrancesco Agostoni 《European heart journal》2007,28(14):1782-3; author reply 1783
22.
23.
Giacomina Brunetti Graziana Colaianni Maria Felicia Faienza Silvia Colucci Maria Grano 《Clinical reviews in bone and mineral metabolism》2013,11(3-4):94-102
Tumor-induced bone disease is a common clinical feature of hematological and metastatic solid cancer. Thus, numerous scientists have gained a better understanding of the mechanisms by which certain tumor types tend to invade specifically the bone. Firstly, Stephen Paget recognized the ‘seed and soil’ hypothesis, stating that cancer cells (the ‘seeds’) can only develop in secondary organs where the microenvironment (the ‘soil’–the bone) is permissive for their growth. Today, this theory has been enlarged to the metastatic process in general, because in order to grow in distant organs, tumor cells need special properties that suit them to those organs. Specifically, in order to metastasize to bone, cancer cells firstly detach from their tissue of origin, subsequently transit through circulation, reside in the bone marrow, and acquire a bone cell-like phenotype responsible for bone establishment and invasion. Each step in the metastatic cascade is rich in biological targets and mechanistic pathways, which are summarized in this review. 相似文献
24.
Roberto Tamma Li Sun Concetta Cuscito Ping Lu Michelangelo Corcelli Jianhua Li Graziana Colaianni Surinder S. Moonga Adriana Di Benedetto Maria Grano Silvia Colucci Tony Yuen Maria I. New Alberta Zallone Mone Zaidi 《Proceedings of the National Academy of Sciences of the United States of America》2013,110(46):18644-18649
Although hyponatremia is known to be associated with osteoporosis and a high fracture risk, the mechanism through which bone loss ensues has remained unclear. As hyponatremic patients have elevated circulating arginine-vasopressin (AVP) levels, we examined whether AVP can affect the skeleton directly as yet another component of the pituitary-bone axis. Here, we report that the two Avp receptors, Avpr1α and Avpr2, coupled to Erk activation, are expressed in osteoblasts and osteoclasts. AVP injected into wild-type mice enhanced and reduced, respectively, the formation of bone-resorbing osteoclasts and bone-forming osteoblasts. Conversely, the exposure of osteoblast precursors to Avpr1α or Avpr2 antagonists, namely SR49059 or ADAM, increased osteoblastogenesis, as did the genetic deletion of Avpr1α. In contrast, osteoclast formation and bone resorption were both reduced in Avpr1α−/− cultures. This process increased bone formation and reduced resorption resulted in a profound enhancement of bone mass in Avpr1α−/− mice and in wild-type mice injected with SR49059. Collectively, the data not only establish a primary role for Avp signaling in bone mass regulation, but also call for further studies on the skeletal actions of Avpr inhibitors used commonly in hyponatremic patients.Over the past decade, studies by others and us have documented direct effects of pituitary hormones on the skeleton. We have identified functional receptors for thyroid stimulating hormone (TSH), follicle stimulating hormone (FSH), adrenocorticotropic hormone (ACTH), and oxytocin (OT) on murine and human bone cells, namely bone-forming osteoblasts and bone-resorbing osteoclasts (1–4). The genetic deletion of either the receptor or the ligand itself, as in the case of FSH and OT, results in overt skeletal abnormalities. Specifically, deleting OT or its receptor, the Oxtr, causes profound osteopenia, which primarily arises from a dramatic reduction in bone formation by the osteoblast (4). Such studies have helped establish a pituitary-bone axis, in which pituitary hormones bypass their known targets, such as the thyroid, ovaries, adrenal, and breast, to regulate bone directly (5).This growing body of data not only informs us of novel functions of pituitary hormones, but also explains the hitherto poorly understood mechanisms of certain forms of osteoporosis, which have traditionally been attributed solely to changes in distal hormones. For example, we find that low TSH signaling contributes to the bone loss in hyperthyroidism, which was thought solely to be a result of elevated thyroid hormones (6). We have also speculated that the rapid bone loss that occurs during late perimenopause, at a time when estradiol levels are relatively normal, could—at least in part—be caused by elevated serum FSH levels. Thus, an antibody to FSH reduces bone loss in ovariectomized mice by stimulating bone formation and inhibiting bone resorption (7). Similarly, through its skeletal anabolic actions, elevated OT levels during pregnancy and lactation could play a major role in enabling fetal skeletal mineralization and allowing the mother to recover from the osteoporosis caused by the intergenerational transfer of calcium (8).Here, we report studies on arginine-vasopressin (AVP), another posterior pituitary hormone, which differs from OT only by two amino acids (9). The direct skeletal actions of AVP have never been explored, despite multiple and recurring observations that hyponatremia, which is invariably accompanied by elevated plasma AVP levels, is associated with bone loss and a high fracture risk (10–16). It has been thought that, as bone is a large reservoir for sodium ions, hyponatremia will trigger sodium release from the skeleton by increasing bone resorption (17, 18). However, the molecular basis of any such effect remains unknown. Interestingly, a recent study has described a male patient with syndrome of inappropriate secretion of antidiuretic hormone- (SIADH) induced hyponatremia, who had severe osteoporosis, despite having no identifiable risk factors (19). Plasma AVP was elevated by ∼30-fold, raising the possibility that high circulating AVP levels may cause the profound bone loss.We show that AVP is a key regulator of bone resorption and formation, the two principal components of bone remodeling. Both Avp receptors, Avpr1α and Avpr2, are expressed on osteoclasts and osteoblasts, and their stimulation triggers extracellular signal regulated kinase (Erk) activation, which in turn suppresses bone formation and stimulates bone resorption. This decoupling would favor bone loss, as noted in hyponatremic states. However, we also find that the genetic deletion of Avpr1 or the pharmacologic inhibition of Avpr1 or Avpr2 increases bone mass not only by stimulating osteoblastogenesis and new bone synthesis, but also by simultaneously inhibiting osteoclast formation and bone resorption. We speculate, therefore, that the targeted therapy of hyponatremia with aquaretics (or AVPR inhibitors) could result in overall bone gain. Purposefully designed clinical studies in populations in whom hyponatremia is a significant clinical problem (20), and whom are otherwise also at a high risk for fracture (21), should shed further light on the proposed osteoprotective action of AVPR antagonists in people. 相似文献
25.
Classic Hodgkin's Lymphoma is a disease usually characterized by lymph nodal presentation. Rare cases with extra-nodal first clinical manifestation may occur, and primary bone marrow involvement may be part of them: isolated bone marrow forms have been recently described in the context of HIV infection. We herein report a case of isolated bone marrow Hodgkin's Lymphoma occurrence in a HIV-negative, elderly patient. The impacts of such unusual Hodgkin's Lymphoma manifestation on clinical practice as well as the related diagnostic and therapeutic implications are discussed. 相似文献
26.
Alessandra Micera Katerina Jirsova Eduardo Maria Normando Barbara Stampachiacchiere Graziana Esposito Alessandro Lambiase Stefano Bonini 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2014,252(2):267-274
Background
To assess the expression of toll-like receptors (TLRs) in human amniotic membrane (AM) specimens and compare this expression with those of AMs undergoing the standard preservation procedure (handling) for ocular surgery.Methods
Human fresh (n?=?10; five spontaneous and five cesarean) or handled (n?=?5) AMs were analyzed for TLR gene and protein expression. Two pieces were obtained from each specimen, and subjected to molecular or biochemical analysis. Relative real-time PCR and SDS-PAGE were carried out according to standard procedures. The REST–ANOVA coupled analysis was used to compare the molecular and biochemical data.Results
The fresh membranes expressed all the TLRs (TLR1-10), with different gene expression as detected/evidenced by the Ct values, the intra-fresh group analysis showing that there was a variation of TLR expression whichvaried within the fresh membranes. The handled AMs retained the TLR expression after standard processing and preservation, but with a particular pattern which included a high TLR3/TLR4 and low TLR6 expression, when compared to the fresh membranes. The molecular data were confirmed by Western blot analysis.Conclusions
AM is routinely used in several ophthalmic surgical procedures, and notwithstanding its preservation procedure, AM is reported to favour wound healing and exert anti-angiogenic, anti-inflammatory, anti-scarring as well as anti-bacterial activities. The presence of TLRs in handled AM would imply that TLRs might be preserved in AMs used in ocular surgery. The findings herein described provide additional data concerning the presence of TLRs in cryopreserved AM, and suggest a possible contribution of AM in ocular surgery, via the innate immune response. 相似文献27.
Baliram R Latif R Berkowitz J Frid S Colaianni G Sun L Zaidi M Davies TF 《Proceedings of the National Academy of Sciences of the United States of America》2011,108(39):16277-16282
We have shown that the anterior pituitary hormone, thyroid-stimulating hormone (TSH), can bypass the thyroid to exert a direct protective effect on the skeleton. Thus, we have suggested that a low TSH level may contribute to the bone loss of hyperthyroidism that has been attributed traditionally to high thyroid hormone levels. Earlier mouse genetic, cell-based, and clinical studies together have established that TSH inhibits osteoclastic bone resorption. However, the direct influence of TSH on the osteoblast has remained unclear. Here, we have used a model system developed from murine ES cells, induced to form mature mineralizing osteoblasts, and show that TSH stimulates osteoblast differentiation primarily through the activation of protein kinase Cδ and the up-regulation of the noncanonical Wnt components frizzled and Wnt5a. We predict that a TSH-induced, fast-forward short loop in bone marrow permits Wnt5a production, which, in addition to enhancing osteoblast differentiation, also stimulates osteoprotegerin secretion to attenuate bone resorption by neighboring osteoclasts. We surmise that this loop should uncouple bone formation from bone resorption with a net increase in bone mass, which is what has been observed upon injecting TSH. 相似文献
28.
Graziana Gallo Heinz Kutzner Thomas Mentzel Anna M. Cesinaro 《Journal of cutaneous pathology》2019,46(1):80-83
Cellular neurothekeoma (CNT) is a dermal lesion with still unknown histogenesis, characterized by immunohistochemical staining for NKI/C3, NSE, MiTF, CD10 and CD68, whereas S100 protein, desmin and cytokeratins are negative. Particularly, in several studies NKI/C3 has been reported as a strong marker of CNT. We describe herein the clinical, histopathological and immunohistochemical features of two cases morphologically consistent with myxoid CNT, one of which showing some atypical features, both characterized by negative immunohistochemical staining for NKI/C3. Our findings stress the importance of morphology in diagnosing CNT and underline the fact that NKI/C3 can fail to stain cases belonging to the “neurothekeoma family.” In selected cases of CNT, an expanded immunohistochemical panel is mandatory to differentiate this tumor from other dermal lesions. 相似文献
29.
30.
Poli A Marangoni F Paoletti R Mannarino E Lupattelli G Notarbartolo A Aureli P Bernini F Cicero A Gaddi A Catapano A Cricelli C Gattone M Marrocco W Porrini M Stella R Vanotti A Volpe M Volpe R Cannella C Pinto A Del Toma E La Vecchia C Tavani A Manzato E Riccardi G Sirtori C Zambon A;Nutrition Foundation of Italy 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2008,18(2):S1-16
The importance of non-pharmacological control of plasma cholesterol levels in the population is increasing, along with the number of subjects whose plasma lipid levels are non-optimal, or frankly elevated, according to international guidelines. In this context, a panel of experts, organized and coordinated by the Nutrition Foundation of Italy, has evaluated the nutritional and lifestyle interventions to be adopted in the control of plasma cholesterol levels (and specifically of LDL cholesterol levels). This Consensus document summarizes the view of the panel on this topic, with the aim to provide an updated support to clinicians and other health professionals involved in cardiovascular prevention. 相似文献